BioProtect

📍 Netanya, Israel👥 125 employees💰 Last funded Mar 2020
Medical Device🌐 bioprotect.com
Website LinkedIn
BioProtect is advancing rectal spacing through controllable, biodegradable balloon technology. Our proprietary balloon spacer is engineered to provide consistent, predictable separation from apex to base, enabling modern, high-precision radiation therapy. The FDA-cleared BioProtect Balloon Spacer has shown reduced rectal dose, a favorable safety profile, and durable preservation of bowel, urinary, and sexual quality of life through 48 months. Its performance supports use across today’s advanced prostate cancer treatment regimens, including hypofractionation and SBRT.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Israel
2
Frequently asked questions
Who invested in BioProtect?
BioProtect has 2 investors on record on gritt.io.
When did BioProtect last raise funding?
The most recent investment in BioProtect recorded on gritt.io was in March 2020.
What industry is BioProtect in?
BioProtect operates in Medical Device. Find similar Medical Device investors on gritt.io.
Where is BioProtect based?
BioProtect is headquartered in Netanya, Israel.